Deficient Phosphorylation of Stat1 in Leukocytes Identifies Neutralizing Antibodies in Multiple Sclerosis Patients Treated with Interferon-Beta

• Sonia Gavasso ,

  * E-mail: sonia.gavasso@helse-bergen.no

  Affiliations Department of Neurology, Haukeland University Hospital, Bergen, Norway, The Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Ellen Faergestad Mosleth,

  Affiliation Nofima, Ås, Norway

  ⨯
• Tove Marøy,

  Affiliation The Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Katarina Jørgensen,

  Affiliation Department of Clinical Science, Hematology Section, University of Bergen, Bergen, Norway

  ⨯
• Hanne-Linda Nakkestad,

  Affiliation Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Bjørn-Tore Gjertsen,

  Affiliations Department of Clinical Science, Hematology Section, University of Bergen, Bergen, Norway, Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway

  ⨯
• Kjell-Morten Myhr,

  Affiliations Department of Neurology, Haukeland University Hospital, Bergen, Norway, The Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway, The KG Jebsen Centre for MS Research, University of Bergen, Bergen, Norway

  ⨯
• Christian Vedeler

  Affiliations Department of Neurology, Haukeland University Hospital, Bergen, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway, The KG Jebsen Centre for MS Research, University of Bergen, Bergen, Norway

  ⨯